Collagenase: a key enzyme in collagen turnover
- 1 December 1996
- journal article
- review article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 74 (6) , 759-775
- https://doi.org/10.1139/o96-083
Abstract
The primary agents responsible for cartilage and bone destruction in joint diseases are active proteinases that degrade collagen and proteoglycan. All four main classes of proteolytic enzymes are involved in either the normal turnover of connective tissue or its pathological destruction. These proteinases are made by different cells found within the joints. Both extracellular and intracellular pathways exist and individual enzymes can be inhibited by specific proteinaceous inhibitors that block their activity. Recent research has implicated the matrix metalloproteinases (MMPs) in many of the processes involved in joint diseases. The metalloproteinases are capable of degrading all components of the extracellular matrix. This family of proteinases contains a group of at least three collagenases that are capable of degrading native fibrillar collagen. Collagen degradation within joint disease is recognized as the irreversible step in the destruction of cartilage that leads to a failure in joint function. The collagenases are the enzymes necessary to initiate collagen turnover in normal connective tissue turnover and in disease.Keywords
This publication has 138 references indexed in Scilit:
- Inflammation and Matrix Metalloproteinases in the Enlarging Abdominal Aortic AneurysmArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Protease inhibitors: Role and potential therapeutic use in human cancerEuropean Journal Of Cancer, 1994
- Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a reviewBreast Cancer Research and Treatment, 1993
- The Recombinant Catalytic Domain of Human Neutrophil Collagenase Lacks Type I Collagen Substrate SpecificityBiochemical and Biophysical Research Communications, 1993
- Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13Biochemistry, 1992
- Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling corneaDevelopmental Biology, 1991
- An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenaseBiochemistry, 1991
- Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.Journal of Clinical Investigation, 1989
- Transforming growth factor-beta causes partial inhibition of interleukin 1 — Stimulated cartilage degradation in vitroBiochemical and Biophysical Research Communications, 1989
- Fibroblast growth factor enhances the interleukin-1-mediated chondrocytic protease releaseBiochemical and Biophysical Research Communications, 1987